Ruxolitinib phosphate
Pharmaceutical solutions
Introduction
Ruxolitinib is a Janus-associated kinase (JAK) inhibitor used in the treatment of myelofibrosis, atopic dermatitis and vitiligo
Technical characteristics
CAS N°: 1092939-17-7
Empirical formula: C17H21N6O4P
GMP
State: Solid
Antineoplastic and immunomodulating agents
Ruxolitinib phosphate applications
APIs
Oncology